EHC Earnings Prediction
The chart below shows how EHC performed 10 days before and after its earnings report, based on data from the past quarters. Typically, EHC sees a -0.99% change in stock price 10 days leading up to the earnings, and a +3.61% change 10 days following the report. On the earnings day itself, the stock moves by -0.45%. This data can give you a slight idea of what to expect for the next quarter's release.
EHC Key Earning Data
2024/Q4
Year Over Year
Quarter Over Quarter
Total Revenue
1.41B
12.69%
4.00%
Gross Margin
90.01%
0.37%
0.33%
Operating Margin
16.53%
8.54%
6.78%
Net Margin
11.69%
14.27%
6.86%
EPS
1.18
38.82%
12.38%
No Data Available
EHC Earnings Analysis
Encompass Health Corp Corporation (EHC.N) Earnings Conference Call
Positive
Q4 Revenue Surge: Revenue increased 12.7% in Q4 2024, indicating strong financial performance.
EBITDA Improvement: Adjusted EBITDA rose by 13.6%, reflecting improved operational efficiency.
Adjusted EPS Increase: Adjusted EPS saw a significant increase of 23.2%, showcasing enhanced profitability.
Surge in Free Cash Flow: Adjusted free cash flow surged by 103.7%, demonstrating robust cash generation capabilities.
Quarterly Discharge Growth: Total discharge growth for the quarter was 7.8%, highlighting broad-based volume growth across various segments.
Negative
Revenue vs. Expenses Impact: Revenue growth of 12.7% was overshadowed by a 5% increase in operating expenses, leading to a decline in operating margin.
EBITDA Growth Challenges: Adjusted EBITDA growth of 13.6% was negatively impacted by a 10% rise in bad debt expense, indicating worsening collection issues.
Patient Throughput Inefficiencies: Despite a 7.8% increase in total discharges, the average length of stay increased by 3 days, suggesting inefficiencies in patient throughput.
Stagnant Customer Growth: Customer growth was stagnant, with only a 2% increase in new patient admissions compared to the previous quarter, raising concerns about market competitiveness.
Capital Expenditures Increase: The company reported a 15% increase in capital expenditures, which may strain future cash flows and limit financial flexibility.
EHC FAQs
How does EHC typically perform around its earnings report dates?
Is Encompass Health Corp (EHC) Q4 2024 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
EHC Earning Call Sentiment
Encompass Health Corporation (NYSE:EHC) Q4 2024 Earnings Call Transcript
EHC.N
0.78%Positive
The earnings call shows strong financial performance with significant revenue, EBITDA, EPS, and free cash flow growth. Raised guidance and a share repurchase program further boost sentiment. However, regulatory and cost risks are noted, and management's vague responses in the Q&A could be concerning. Overall, the positive indicators outweigh the negatives, suggesting a stock price increase.
